Drug intelligence / Profile preview

ciprofloxacin + tinidazole

Development stage
Unknown
Lead developer
Exphar
Modality
Small Molecules
Administration
Oral
01

Overview

Ciprofloxacin + tinidazole is a fixed-dose combination of two antimicrobial agents used to treat a broad range of bacterial and protozoal infections. Ciprofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and repair in bacteria, leading to cell death. Tinidazole is a nitroimidazole derivative with antiprotozoal and antibacterial activity; it works by damaging the DNA of anaerobic bacteria and protozoa, preventing their growth and multiplication. This combination is commonly prescribed for gastrointestinal infections (including traveler’s diarrhea), gynecological infections, certain sexually transmitted diseases (such as trichomoniasis), amebiasis, giardiasis, as well as for prophylaxis after surgery[1][2][4][5]. It has also been studied in chronic refractory pouchitis[8].

Brand names
Fluoxine T
Other names
ciprofloxacin and tinidazoletinidazole + ciprofloxacinciprofloxacin+tinidazole
02

Targets

DNA gyraseTopo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on ciprofloxacin + tinidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ciprofloxacin + tinidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call